期刊
SCIENTIFIC REPORTS
卷 11, 期 1, 页码 -出版社
NATURE RESEARCH
DOI: 10.1038/s41598-021-86220-3
关键词
-
资金
- German Research Foundation [SFB779/A06, DFG Wa2673/4-1, 362321501/RTG 2413 SynAGE, CRC1436 TPA07]
- Center for Behavioral Brain Sciences [CBBS NN05]
- EU/EFRE- Autonomy In Old Age Research Alliance of the State of Saxony-Anhalt
- DFG GRK SynAge
This study found that the Met allele of the Val66Met SNP of the BDNF gene is associated with lower Glx/NAA ratio in the pregenual anterior cingulate cortex (pgACC). Met carriers did not show decreased glutamate or glutamine levels, but instead exhibited increased NAA compared to Val homozygotes. This finding may help explain conflicting evidence regarding Val66Met as a risk factor for developing psychiatric illnesses.
The Met allele of the Val66Met SNP of the BDNF gene (rs6265) is associated with impaired activity-dependent release of brain-derived neurotrophic factor (BDNF), resulting in reduced synaptic plasticity, impaired glutamatergic neurotransmission, and morphological changes. While previous work has demonstrated Val66Met effects on magnetic resonance spectroscopy (MRS) markers of either glutamatergic metabolism (Glx) or neuronal integrity (NAA), no study has investigated Val66Met effects on these related processes simultaneously. As these metabolites share a metabolic pathway, the Glx/NAA ratio may be a more sensitive marker of changes associated with the Val66Met SNP. This ratio is increased in psychiatric disorders linked to decreased functioning in the anterior cingulate cortex (ACC). In this study, we investigated the correlation of the Val66Met polymorphism of the BDNF gene with Glx/NAA in the pregenual anterior cingulate cortex (pgACC) using MRS at 3 Tesla (T) (n=30, all males) and 7 T (n=98, 40 females). In both cohorts, Met carriers had lower Glx/NAA compared to Val homozygotes. Follow-up analyses using absolute quantification revealed that the Met carriers do not show decreased pgACC glutamate or glutamine levels, but instead show increased NAA compared to the Val homozygotes. This finding may in part explain conflicting evidence for Val66Met as a risk factor for developing psychiatric illnesses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据